New chemical entities

Most of the marketed drugs are small molecular weight compounds, these therapeutic products have already made a huge difference to people’s lives treating a wide range of diseases.  New chemical entities are continually being developed and product specific strategies are required to meet regulatory requirements.  At Envigo, we share that same future with you. United with our customers in the pursuit of the next wave of new chemical entities, we have unrivalled experience and expertise helping companies like yours develop your novel small molecular weight therapeutic products.

When we talk about commitment, it isn’t just another word.  We can back that up with experience working on the development of over thousands of small molecule drugs, to the marketplace and beyond.

Expand All Tabs
  • Drug development consultancy and advice
  • Discovery services and lead candidate selection
  • In vitro and in vivo discovery pharmacology and efficacy studies
  • GLP compliant non-clinical safety assessment
  • cGMP batch release and stability testing
  • Clinical PK, immunogenicity and biomarker services
  • Clinical study services
  • Regulatory affairs

The future of inhaled medications and inhalation technology

[Webinar] De-risking drug development: in vitro strategies that add value to your molecule